Related Experiment Video
Updated: Jun 19, 2026

07:34
Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
Published on: November 17, 2023
Morphologic characterization of preoperatively treated prostate cancer: toward a post-therapy histologic
Eleni Efstathiou1, Neil A Abrahams, Rita F Tibbs
1University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
European Urology
|October 27, 2009
Summary
Preoperative treatment alters prostate cancer (PCa) morphology, invalidating the Gleason score. This study classifies pretreated PCa into three groups, identifying new predictors of biochemical relapse.
Area of Science:
- Oncology
- Pathology
- Urology
Background:
- Preoperative treatment for prostate cancer (PCa) significantly alters tumor morphology.
- This alteration renders the traditional Gleason score unreliable for assessing residual disease.
- There is a need to re-evaluate PCa morphology post-treatment.
Purpose of the Study:
- To systematically classify the morphologic features of preoperatively treated PCa.
- To identify novel morphologic classifiers that predict treatment outcomes.
- To establish a standardized method for evaluating post-treatment PCa specimens.
Main Methods:
- Detailed morphologic evaluation of 115 high-risk PCa specimens from patients receiving preoperative androgen ablation (with or without chemotherapy).
- Hierarchical clustering analysis of observed morphologic characteristics.
- Univariate and multivariate analyses to correlate morphology with pathologic parameters and disease outcomes.
Main Results:
- Three distinct morphologic groups (A, B, C) of pretreated PCa were identified using hierarchical clustering.
- Group A: Predominance of cell clusters, cords, and isolated cells.
- Group C: Characterized by cribriform growth pattern or intraductal spread, strongly associated with biochemical relapse.
- Cribriform pattern and intraductal spread were stronger predictors of relapse than pathologic stage on multivariate analysis.
Conclusions:
- A novel classification system for preoperatively treated PCa based on distinct morphologic patterns has been developed.
- This classification may improve uniformity in biomarker studies and facilitate inter-institutional trial comparisons.
- The proposed morphologic classifier shows potential as a new prognostic tool for preoperatively treated prostate cancer.

